• Login
    View Item 
    •   Home
    • UMass Chan Faculty and Staff Research and Publications
    • COVID-19 Publications by UMass Chan Authors
    • View Item
    •   Home
    • UMass Chan Faculty and Staff Research and Publications
    • COVID-19 Publications by UMass Chan Authors
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of eScholarship@UMassChanCommunitiesPublication DateAuthorsUMass Chan AffiliationsTitlesDocument TypesKeywordsThis CollectionPublication DateAuthorsUMass Chan AffiliationsTitlesDocument TypesKeywordsProfilesView

    My Account

    LoginRegister

    Help

    AboutSubmission GuidelinesData Deposit PolicySearchingUsage StatisticsAccessibilityTerms of UseWebsite Migration FAQ

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Management of primary skin cancer during a pandemic: Multidisciplinary recommendations

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Baumann, Brian C.
    MacArthur, Kelly M.
    Brewer, Jerry D.
    Mendenhall, William M.
    Barker, Christopher A.
    Etzkorn, Jeremy R.
    Jellinek, Nathaniel
    Scott, Jeffrey F.
    Gay, Hiram A.
    Baumann, John C.
    Manian, Farrin A.
    Devlin, Phillip M.
    Michalski, Jeff M.
    Lee, Nancy Y.
    Thorstad, Wade L.
    Wilson, Lynn D.
    Perez, Carlos A.
    Miller, Christopher J.
    Show allShow less
    UMass Chan Affiliations
    Department of Dermatology
    Document Type
    Journal Article
    Publication Date
    2020-06-01
    Keywords
    Merkel cell carcinoma
    Mohs surgery
    basal cell carcinoma
    coronavirus disease 2019
    COVID-19
    cutaneous squamous cell carcinoma
    melanoma
    radiotherapy
    skin cancer
    treatment delays
    Dermatology
    Health Services Administration
    Infectious Disease
    Neoplasms
    Oncology
    Skin and Connective Tissue Diseases
    Virus Diseases
    Show allShow less
    
    Metadata
    Show full item record
    Link to Full Text
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301000/
    Abstract
    During the coronavirus disease 2019 (COVID-19) pandemic, providers and patients must engage in shared decision making regarding the pros and cons of early versus delayed interventions for localized skin cancer. Patients at highest risk of COVID-19 complications are older; are immunosuppressed; and have diabetes, cancer, or cardiopulmonary disease, with multiple comorbidities associated with worse outcomes. Physicians must weigh the patient's risk of COVID-19 complications in the event of exposure against the risk of worse oncologic outcomes from delaying cancer therapy. Herein, the authors have summarized current data regarding the risk of COVID-19 complications and mortality based on age and comorbidities and have reviewed the literature assessing how treatment delays affect oncologic outcomes. They also have provided multidisciplinary recommendations regarding the timing of local therapy for early-stage skin cancers during this pandemic with input from experts at 11 different institutions. For patients with Merkel cell carcinoma, the authors recommend prioritizing treatment, but a short delay can be considered for patients with favorable T1 disease who are at higher risk of COVID-19 complications. For patients with melanoma, the authors recommend delaying the treatment of patients with T0 to T1 disease for 3 months if there is no macroscopic residual disease at the time of biopsy. Treatment of tumors > /=T2 can be delayed for 3 months if the biopsy margins are negative. For patients with cutaneous squamous cell carcinoma, those with Brigham and Women's Hospital T1 to T2a disease can have their treatment delayed for 2 to 3 months unless there is rapid growth, symptomatic lesions, or the patient is immunocompromised. The treatment of tumors > /=T2b should be prioritized, but a 1-month to 2-month delay is unlikely to worsen disease-specific mortality. For patients with squamous cell carcinoma in situ and basal cell carcinoma, treatment can be deferred for 3 months unless the individual is highly symptomatic.
    Source

    Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer. 2020 Jun 1:10.1002/cncr.32969. doi: 10.1002/cncr.32969. Epub ahead of print. PMID: 32478867; PMCID: PMC7301000. Link to article on publisher's site

    DOI
    10.1002/cncr.32969
    Permanent Link to this Item
    http://hdl.handle.net/20.500.14038/27610
    PubMed ID
    32478867
    Related Resources

    Link to Article in PubMed

    ae974a485f413a2113503eed53cd6c53
    10.1002/cncr.32969
    Scopus Count
    Collections
    COVID-19 Publications by UMass Chan Authors

    entitlement

    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Lamar Soutter Library, UMass Chan Medical School | 55 Lake Avenue North | Worcester, MA 01655 USA
    Quick Guide | escholarship@umassmed.edu
    Works found in eScholarship@UMassChan are protected by copyright unless otherwise indicated.
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.